NEW
BRUNSWICK, N.J., April 19,
2022 /PRNewswire/ -- Johnson & Johnson
(NYSE: JNJ) today announced that its Board of Directors has
declared a 6.6% increase in the quarterly dividend, from
$1.06 per share to $1.13 per share.
"In recognition of our 2021 results, strong financial position,
and confidence in the future of Johnson & Johnson, the Board of
Directors has voted to increase the quarterly dividend for the 60th
consecutive year," said Joaquin
Duato, Chief Executive Officer of the company.
At the new rate, the indicated dividend on an annual basis is
$4.52 per share compared to the
previous rate of $4.24 per share. The
next quarterly dividend is payable on June
7, 2022 to shareholders of record as of the close of
business on May 24, 2022. The
ex-dividend date is May 23, 2022.
About Johnson & Johnson
At Johnson & Johnson, we believe good health is the foundation
of vibrant lives, thriving communities and forward progress. That's
why for more than 130 years, we have aimed to keep people well at
every age and every stage of life. Today, as the world's largest
and most broadly-based health care company, we are committed to
using our reach and size for good. We strive to improve access and
affordability, create healthier communities, and put a healthy
mind, body and environment within reach of everyone, everywhere. We
are blending our heart, science and ingenuity to profoundly change
the trajectory of health for
humanity.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/johnson--johnson-announces-dividend-increase-of-6-6-301527648.html
SOURCE Johnson & Johnson